Navigation Links
Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
Date:1/9/2008

- Former CEO David Shaw Named Executive Chairman and Chairman of the Board

-

CLINTON, N.J., Jan. 9 /PRNewswire/ -- Ikaria Holdings, Inc., a fully integrated critical care biopharmaceutical company, announced today that Daniel Tasse has been appointed President and Chief Executive Officer. Mr. Tasse succeeds David Shaw, who has served as Chairman and interim CEO since the creation of Ikaria Holdings in March 2007 and will now serve as Executive Chairman and Chairman of the Board.

Mr. Shaw commented, "Daniel is an outstanding fit for the Ikaria opportunity, and vice versa. He has extensive executive management experience in 'academy companies' in the pharmaceutical and life sciences industry, with highly relevant expertise in R&D management, marketing and sales, and other functions in domestic and international markets. We expect to benefit strategically and operationally from Daniel's many years of involvement in both drugs and devices across many therapeutic areas and healthcare settings, including critical care. His leadership capabilities and his knowledge of in- hospital markets will be particularly valuable as Ikaria continues to build an exceptionally strong capability to serve the needs of critically ill patients."

Daniel Tasse stated, "The formation of Ikaria last year created a company with the potential to redefine the critical care industry. With Ikaria's industry-leading INOmax(R) product and a pipeline of unique therapeutic compounds and numerous business development and R&D opportunities, we have a very exciting and unique opportunity available to us. I feel very fortunate to join this team in a leadership position with the goal of building a legendary company in the years ahead."

Mr. Tasse most recently served as the General Manager of Baxter International's $2 billion Pharmaceuticals & Technologies business, a division created by integrating the company's Anesthesia, Critical Care
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ikaria to Present at 26th Annual JPMorgan Healthcare Conference
2. Ikaria Founding Scientist Named 2007 MacArthur Fellow
3. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
4. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
5. Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors
6. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
7. Access Pharmaceuticals Appoints Jeffrey B. Davis as CEO
8. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
9. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
10. LeMaitre Vascular Appoints Russell D. Hays to Its Board of Directors
11. SGX Pharmaceuticals Appoints Joseph L. Turner to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... 24, 2014 Oramed Pharmaceuticals Inc. ... focused on the development of oral drug delivery systems, ... will present at FireRock Capital,s Micro-Cap Conference. ... Conference ,Date: Tuesday, October 28, 2014 ,Time: 9:15am EST ... York City , About The ...
(Date:10/25/2014)... 2014 ... announced the addition of the  "The Global ... 2-D Nanomaterials "  report to their offering.  ... and graphene are the strongest, lightest and ... a performance-per-weight greater than any other material. ...
(Date:10/22/2014)... The North American crystal oscillator market report ... analysis and forecast of revenue. This market was valued ... reach $623.6 million by 2018, at a CAGR of ... TOC of the North American crystal oscillator market report, ... This also provides a glimpse of the segmentation of ...
(Date:10/22/2014)... Al Khaimah, UAE (PRWEB) October 22, 2014 ... game-changing life science and healthcare projects, announces the addition ... MRCGP DRCOG DCH to its advisory team. Dr. Siddiqui ... advisory team. , A graduate of University ... Siddiqui was subsequently degreed in medicine in 2001. With ...
Breaking Biology Technology:Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 2The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 3The Global Market for Carbon Nanotubes, Graphene and Other 2-D Nanomaterials 4The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Dr. Yousef Siddiqui joins the Grace Century Advisory Team 2
... Mich., April 25 The Fraunhofer Center ... the BU,Center for Nanoscience and Nanobiotechnology hosted ... for a tour of their world class,facilities ... The intensive tour included demonstrations of ...
... April 25 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia,International, Inc. ... "the,Company"), a leading provider in the nutraceutical ... of organic nutritional food,products, supplements, and personal ... ("PRC"), today announced that it has formally ...
... BASINGSTOKE, England and PHILADELPHIA, April 25 /PRNewswire-FirstCall/,-- Shire plc (LSE: ... the three months to March,31, 2008., Q1 2008 ... - New product sales(1) $216m, 34% of product sales ... - US GAAP Operating income up 15% to $163m ...
Cached Biology Technology:Fraunhofer and Boston University Hosted Prestigious SME Tour 2China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network 2China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network 3Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 2Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 3Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 4Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 5Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 6Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 7Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 8Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 9Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 10Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 11Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 12Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 13Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 14Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 15Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 16Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 17Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 18Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 19Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 20Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 21Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 22Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 23Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 24Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 25Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 26Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 27Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 28Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 29Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 30Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 31Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 32Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance 33
(Date:10/17/2014)... knowledge regarding Ebola is critical and pertinent for practicing ... global outbreak and epidemic. The Journal, Disaster Medicine ... issue, Ebola Virus and Public Health, to surround the ... this critical societal moment. , On October 17, ... Clinicians . The primer was prepared by Dr. Eric ...
(Date:10/17/2014)... German . ... When treating overdoses, doctors are often limited to supportive therapy ... is a combination of drugs involved. So what can be ... grandmother,s pills? ETH professor Jean-Christophe Leroux from the Institute of ... to this question. "The task was to develop an agent ...
(Date:10/16/2014)... synthesis of recent research findings to inform their management ... states. , The Ecology and Management of Moist ... of the Relevant Biophysical Science and Implications for Future ... U.S. Forest Service,s Pacific Northwest Research Station, is a ... synthesis of the large body of scientific information on ...
Breaking Biology News(10 mins):Emergency aid for overdoses 2Emergency aid for overdoses 3New report synthesizes best available science on management of moist mixed-conifer forests 2
... Polycyclic Aromatic Compounds (PACs) on terrestrial and benthic invertebrates ... sediment contamination. Effects are assessed exposing the organisms to ... cases this results in highly predictable effects on development ... that the effects of prolonged exposure can be very ...
... researchers under the leadership of Vici-winner Merel Kindt has ... in human volunteers by administering the beta-blocker propranolol. Interestingly, ... of time. Top journal Nature Neuroscience published ... recently, it was assumed that the fear memory could ...
... well crickets adapt to rising temperatures may provide clues ... UCF scientist Wade Winterhalter landed an $860,000 grant ... study that fuses global warming models with a biological ... ground cricket, also known as the Allonemobius socius. ...
Cached Biology News:Soil and sediment contamination assessment more accurate 2An end to fear 2Crickets may predict human survivability during global warming 2
Rat monoclonal [HEK/1/85a] to CCR5 ( Abpromise for all tested applications). entrezGeneID: 1234 SwissProtID: P51681...
... designed for use with the ProQuest Two-Hybrid ... contains deletions in the endogenous GAL4 and ... systems. The strain also has leu2 and ... and prey vectors. MaV203 contains three GAL4 ...
Spastin (Sp 3G11/1)...
Anti-Cullin-1 Host: rabbit polyclonal Species Reactivity: human, mouse Applications: IHC(P), WB, IP Storage: 4C...
Biology Products: